Neonatal pharmacology: Rational therapeutics for the most vulnerable

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 6, 2009, Pages 573-577

  James, L ^a   Ito, S ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; DEOXYCHOLIC ACID; FLUCONAZOLE; SEROTONIN UPTAKE INHIBITOR;

CANDIDEMIA; DRUG METABOLISM; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GASTROSCHISIS; HUMAN; INTESTINE ATRESIA; LOW BIRTH WEIGHT; LUNG BLOOD VESSEL; MALROTATION SYNDROME; MYCOSIS; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NEWBORN MORTALITY; PEDIATRICS; PRIORITY JOURNAL; PUERPERAL DEPRESSION;

CHILD BEHAVIOR; CHILD, PRESCHOOL; CONSUMER PRODUCT SAFETY; DRUG LABELING; DRUG THERAPY; FEMALE; HUMANS; INFANT; INFANT BEHAVIOR; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTENSIVE CARE UNITS, NEONATAL; NERVOUS SYSTEM; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK ASSESSMENT;

EID: 70450145495     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.212     Document Type: Editorial

References (18)

1. Ward, R.M. & Kern S.E. Clinical trials in neonates: a therapeutic imperative. Clin. Pharmacol. Ther. 86, 585-587 (2009).
2. Shirkey, H.C., ed. Pediatric Therapy (C.V. Mosby, St. Louis, 1964).
3. Benjamin, D.K. Jr., Stoll, B.J., Goldberg, R., Walsh, T.J. for the NICHD Neonatal Research Network. Neonatal candidiasis: epidemiology, clinical judgment, and outcomes (abstract). Presented at the annual meeting of the Society for Pediatric Research, Honolulu, Hawaii, 2-6 May 2008.
4. Wade, K.C. et al. Population pharmacokinetics of fluconazole in young infants. Antimicrob. Agents Chemother. 52, 4043-4049 (2008).
5. Kaufman, D., Boyle, R., Hazen, K.D., Patric, J.T., Robinson, M. & Donowitz, L.G. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N. Engl. J. Med. 345, 1660-1666 (2001).
6. Moran, C., Smith, P.B., Cohen-Wolkowiez, M.C. & Benjamin, D.K. Jr. Clinical trial design in neonatal pharmacology: effect of center differences with lessons from the pediatric oncology cooperative research experience. Clin. Pharm. Ther. 86, 589-591 (2009).
7. Mouksassi, M.S., Marier, J.F., Cyran, J. & Vinks, A.A. Clinical trial simulation in pediatric patients using realistic covariates: application to teduglutide, a glucagon-like peptide-2 analog in neonates and infants with short-bowel syndrome. Clin. Pharmacol. Ther. 86, 667-671 (2009
8. Uhl, K. Advancing women's health in the 21st century: applying the tools of clinical pharmacology. Clin. Pharmacol. Ther. 83, 3-7 (2008).
9. Andrade, S.E. et al. Prescription drug use in pregnancy. Am. J. Obstet. Gynecol. 191, 298-407 (2004).
10. Leeder, J.S. Developmental pharmacogenetics: a general paradigm for application to neonatal pharmacology and toxicology. Clin. Pharmacol. Ther. 86, 678-682 (2009)
11. Einarson, A. et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am. J. Psychiatry 165, 749-752 (2008).
12. Chambers, C.D. et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N. Engl. J. Med. 354, 579-587 (2006).
13. Fornaro, E., Li, D., Pan, J. & Belik, J. Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat. Am. J. Respir. Crit. Care Med. 176, 1035-1040 (2007).
14. Oberlander, T.F., Gingrich, J.A. & Ansorge, M.S. Sustained neurodevelopmental effects of intrauterine exposure to SSRI antidepressants: molecular to clinical evidence. Clin. Pharmacol. Ther. 86, 672-677 (2009).
15. Oberlander, T.F., Grunau, R.E., Fitzgerald, C., Papsdorf, M., Rurak, D. & Riggs, W. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 115, 411-425 (2005).
16. Ward, R.M. & Kauffman, R. Future of pediatric therapeutics: reauthorization of BPCA and PREA. Clin. Pharmacol. Ther. 81, 477-479 (2007).
17. Vanchiere, C., Butler, A.S. & Knutsen A. Addressing the Barriers to Pediatric Drug Development: Workshop Summary (National Academies Press, Washington, DC, 2008).
18. Clark, R.H., Bloom, B.T., Spitzer, A.R. & Gerstmann, D.R. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 117, 1979-1987 (2006).